Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Třebíč

4 clinical trials in Třebíč, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Třebíč at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Třebíč

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Chronic kidney disease+1

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Arteriosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Třebíč

What the registry says about research in the country

01 Cardiovascular Research

Innovative research evaluating lipoprotein(a) reduction therapy using novel compounds to prevent major cardiovascular events in high-risk patients.

  • Cardiovascular death prevention
  • Non-fatal stroke management
  • Myocardial infarction risk reduction

Advanced clinical investigations focusing on reducing cardiovascular complications in patients with elevated lipoprotein levels.

02 Atherosclerosis Studies

Groundbreaking trials examining inclisiran therapy for patients with established atherosclerotic cardiovascular disease.

  • ASCVD management
  • LDL-C level reduction
  • Cardiovascular event prevention

Research aimed at improving outcomes for patients with elevated cholesterol levels and vascular disease.

03 Kidney Disease Research

Investigation of combination therapy using baxdrostat and dapagliflozin for patients with concurrent CKD and hypertension.

  • CKD progression management
  • Blood pressure control
  • Renal function preservation

Studies focused on innovative approaches to slow kidney disease progression while managing hypertension.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.